Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG

SANN | SW

Overview

Corporate Details

ISIN(s):
CH1276028821
LEI:
54930035HAOFTTQH0U85
Country:
Switzerland
Address:
HOHENRAINSTRASSE 24, 4133 PRATTELN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare diseases with high unmet medical need. The company's core therapeutic areas of focus are neuromuscular and pulmonary disorders. Its clinical pipeline includes drug candidates for conditions such as Duchenne muscular dystrophy (DMD) and involves the development of advanced treatments like gene therapy for specific congenital muscular dystrophies.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Santhera Pharmaceuticals Holding AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Santhera Pharmaceuticals Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Santhera Pharmaceuticals Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-01-11 N/A Non-Executive member Buy None 42,600.00 CHF
2022-01-10 N/A Executive member Buy None 14,420.00 CHF
2022-01-05 N/A Executive member Buy None 37,000.00 CHF

Peer Companies

Company Country Ticker View
TheraVet SA Logo Belgium ALVET
Thor Medical ASA Logo
Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.
Norway NANOV
Tikun Olam Cannbit Pharmaceuticals Ltd. Logo
Vertically integrated R&D and production of clinically-validated medical cannabis treatments.
Israel TKUN
TMS Co., Ltd Logo Japan 4891
Together Pharma Ltd. Logo
Researches and produces medical cannabis products for domestic and European patients.
Israel TGTR
Japan 4551
TOWA PHARMACEUTICAL CO.,LTD. Logo Japan 4553
TSUMURA & CO. Logo Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish pharma producer of human medicines, vaccines, and high-capacity IV solutions (serum).
Türkiye TRILC
UCB Logo
UCB
A biopharmaceutical firm developing therapies for severe neurological and immunological diseases.
Belgium UCB